Pharmacy News

Image description

FDA approves Lupin generic

Tobramycin Inhalation Solution USP, 300 mg/5 ml, a generic version of Novartis Pharmaceuticals’ TOBI 300 mg/5 ml, is indicated for the management of cystic fibrosis patients with P. aeruginosa.

Image description

FDA approves Parkinson’s drug

Newron Pharmaceuticals’ Xadago was approved as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes.

Image description

Analysis: Entresto improves glycemic control

Entresto lowered HbA1c levels — a measure of average blood glucose levels for the past two to three months — after one year of treatment for heart failure, according to Novartis-funded research.